News News News Outstanding Member Achievement Jobs News Canadian Employers Will Face a $5.6 Billion Price Tag for Specialty Drugs Within the Next Five Years Tuesday, May 10, 2016 Le Lezard (EN) - Express Scripts Canada, one of the country's leading providers of health benefits management services, today announced the results of its annual Drug Trend Report. Germany To Legalize Medical Marijuana Next Year Sunday, May 8, 2016 IFL Science - Germany is set to become the latest country to legalize the use of cannabis for medicinal purposes, with the nation’s health minister confirming earlier this week that the German cabinet had approved the move. Valeant Pharmaceuticals announces shakeup on its board of directors Friday, May 6, 2016 Valeant Pharmaceuticals is shaking up its board of directors, with half of them not standing for re-election, the Quebec-based drugmaker announced Friday. Concordia Healthcare: Diving deep into claims of sky high prices Friday, May 6, 2016 BNN - Business News Network - Anyone with a passing interest in healthcare knows the practice of drug price increases has come under scrutiny lately. Concerns around this scrutiny evolving into new regulations or legal troubles have wiped out stock values in the process. Valeant is going to review how it sets prices for drugs (May 06, 2016 ) Friday, May 6, 2016 CTV Montreal News - Embattled drug manufacturer Valeant Pharmaceuticals International (TSX:VRX) is revamping the way it prices drugs. The company issued a statement late Thursday saying it is forming a new "patient access and pricing committee" that will be responsible for what it charges for prescription drugs. FDA takes significant steps to protect Americans from dangers of tobacco through new regulation Thursday, May 5, 2016 Le Lezard (EN) - The U.S. Food and Drug Administration finalized a rule extending its authority to all tobacco products, including e-cigarettes, cigars, hookah tobacco and pipe tobacco, among others. Warren Buffett calls Valeant strategy 'flawed' Monday, May 2, 2016 Toronto - CBC News - Investor Warren Buffett said Berkshire Hathaway has called the business model of Valeant Pharmaceuticals flawed and panned the company's leadership. Vanc Pharmaceuticals Announces Launch of New OTC Product and Provides Update on Sales Force Ramp Up Monday, May 2, 2016 The Canadian Business Journal Cipher Pharmaceuticals Acquires Worldwide Rights to Dalhousie University's Investigational Tattoo Removal Cream Monday, May 2, 2016 Le Lezard (EN)- Cipher Pharmaceuticals Acquires Worldwide Rights to Dalhousie University's Investigational Tattoo Removal Cream Displaying results 51-59 (of 59) |< < 1 - 2 - 3 - 4 - 5 - 6 > >|